comparemela.com
Home
Live Updates
Abbott Laboratories Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6% : comparemela.com
Abbott Laboratories Raises Earnings Forecast, BIIB Provides Rosy Revenue Outlook, ELV Q2 Revenue Up 15.6%
WESTON (dpa-AFX) - The following are some of the biotech companies that reported earnings and provided an update on their pipeline yesterday.1. Abbott Laboratories (ABT), which reported encouraging
Related Keywords
Germany
,
Netherlands
,
North Carolina
,
United States
,
,
Elevance Health Inc
,
Biogen Inc
,
Akari Therapeutics Plc
,
Therapeutics Plc
,
Paramount Advantage
,
Medicare Advantage
,
Integra Managed Care
,
Healthy Blue
,
Abbott
,
Laboratories
,
Raises
,
Earnings
,
Forecast
,
Biogen
,
Rovides
,
Rosy
,
Revenue
,
Outlook
,
Relevance
,
Health
,
comparemela.com © 2020. All Rights Reserved.